Product
ganetespib
1 clinical trial
3 indications
Indication
Recurrent Fallopian Tube CancerIndication
Ovarian CancerClinical trial
A Phase I/II Trial of Weekly Paclitaxel In Combination With Ganetespib In Patients With Recurrent, Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal CancerStatus: Terminated, Estimated PCD: 2016-05-09